For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Prevail Therapeutics, Inc.

USPTO Granted Patents = 15

EPO Patents = 1

Forward Citations = 23

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Asa Abeliovich (14 out of 16 patents)

Laura Heckman (14 out of 14 patents)

Herve Rhinn (13 out of 13 patents)

4. Franz Hefti (3 out of 3 patents)

5. Li Chin Wong (2 out of 2 patents)

6. Hsuan-Ni Lin (2 out of 2 patents)

7. Jorge Haller (1 out of 2 patents)

8. Garrett Daniels (1 out of 1 patent)

9. Jonathan Chan (1 out of 1 patent)

10. Stuart Nelson (1 out of 1 patent)

11. Yong Dai (1 out of 1 patent)

12. Herve Rhinn (1 out of 1 patent)

13. Jingmin Zhou (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 12729385 - RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME (2026-09-08),

2. 12571002 - GENE THERAPIES FOR LYSOSOMAL DISORDERS (2026-03-10),

3. 12570963 - GENE THERAPIES FOR LYSOSOMAL DISORDERS (2026-03-10),

4. 12516298 - GENE THERAPIES FOR LYSOSOMAL DISORDERS (2026-01-06),

5. 12049626 - Gene therapy for neurodegenerative disorders (2024-07-30),

6. 11999974 - Gene therapies for lysosomal disorders (2024-06-04),

7. 11993790 - Gene therapies for lysosomal disorders (2024-05-28),

8. 11903985 - Gene therapies for lysosomal disorders (2024-02-20),

9. 11807849 - Gene therapies for lysosomal disorders (2023-11-07),

10. 11802294 - Gene therapies for lysosomal disorders (2023-10-31),

11. 11661585 - Gene therapies for lysosomal disorders (2023-05-30),

12. 11655460 - Gene therapies for lysosomal disorders (2023-05-23),

13. 11060113 - Gene therapies for lysosomal disorders (2021-07-13),

14. 10837028 - Gene therapies for lysosomal disorders (2020-11-17),

15. 10689625 - Gene therapies for lysosomal disorders (2020-06-23),

Prevail Therapeutics, Inc. is a biotechnology company based in New York, specializing in the development of gene therapies for neurodegenerative diseases. The organization focuses on harnessing advanced genetic engineering techniques to address unmet medical needs in conditions such as Parkinson's disease and other related disorders. Prevail's innovative approach aims to provide transformative treatment options, leveraging its expertise in molecular biology and therapeutic development to improve patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#495 in New York, NY

#1,219 in New York

#21,026 in US

#39,846 in the World

New York, NY, United States of America

Prevail Therapeutics, Inc.

Forward Citations = 23

13 inventors:

Asa Abeliovich (14 out of 16 patents)

Laura Heckman (14 out of 14 patents)

Herve Rhinn (13 out of 13 patents)

4. Franz Hefti (3 out of 3 patents)

5. Li Chin Wong (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…